Leukotrienes as mediators of airway obstruction

American Journal of Respiratory and Critical Care Medicine

Volumn 158, Issue 5 III, 1998, Pages

  Drazen, Jeffrey M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE;

AIRWAY OBSTRUCTION; BRONCHOSPASM; CONFERENCE PAPER; FATTY ACID METABOLISM; GLUTATHIONE METABOLISM; HUMAN; INFLAMMATION; MEDIATOR RELEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0031761890     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.158.supplement_2.13tac180     Document Type: Conference Paper

References (19)

1. Murphy, R. C., S. Hammarstrom, and B. Samuelsson. 1979. Leukotriene C: a slow-reacting substance from murine mastocytoma cells. Proc. Natl. Acad. Sci. U.S.A. 76:4275-4279.
2. Lewis, R. A., K. F. Austen, J. M. Drazen, D. A. Clark, A. Marfat, and E. J. Corey. 1980. Slow reacting substances of anaphylaxis: identification of leukotrienes C-1 and D from human and rat sources. Proc. Natl. Acad. Sci. U.S.A. 77:3710-3714.
3. Orning, L., S. Hammarstrom, and B. Samuelsson. 1980. Leukotriene D: a slow reacting substance from rat basophilic leukemia cells. Proc. Natl. Acad Sci. U.S.A. 77:2014-2017.
4. Parker, C. W., M. M. Huber, M. K. Hoffman, and S. F. Falkenhein. 1979. Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position: evidence that peroxy groups are present and important for spasmogenic activity. Prostaglandins 18:673-686.
5. Lewis, R. A., J. M. Drazen, K. F. Austen, D. A. Clark, and E. J. Corey. 1980. Identification of the C(6)-S-conjugate of leukotriene A with cysteine as a naturally occurring slow reacting substance of anaphylaxis (SRS-A): importance of the 11-cis-geometry for biological activity. Biochem. Biophys. Res. Commun. 96:271-277.
6. Kellaway, C. H., and E. R. Trethewie. 1940. The liberation of a slow-reacting smooth muscle stimulating substance in anaphylaxis. Q. J. Exp. Physiol. 30:121-145.
7. Drazen, J. M., and K. F. Austen. 1974. Effects of intravenous administration of slow-reacting substance of anaphylaxis, histamine, brady-kinin, and prostaglandin F2alpha on pulmonary mechanics in the guinea pig. J. Clin. Invest. 53:1679-1685.
8. Drazen, J. M., R. A. Lewis, S. I. Wasserman, R. P. Orange, and K. F. Austen. 1979. Differential effects of a partially purified preparation of slow-reacting substance of anaphylaxis on guinea pig tracheal spirals and parenchymal strips. J. Clin. Invest. 63:1-5.
9. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568-575.
10. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237:1171-1176.
11. Dennis, E. A. 1990. Modification of the arachidonic acid cascade through phospholipase A2 dependent mechanisms. Adv. Prostaglandin Tliromboxane Leukot. Res. 20:217-223.
12. Davidson, F. F., and E. A. Dennis. 1989. Biological relevance of lipocortins and related proteins as inhibitors of phospholipase A2. Biochem. Phannacol. 38:3645-3651.
13. Waite, M. 1990. Phospholipases, enzymes that share a substrate class. Adv. Exp. Med. Biol. 279:1-22.
14. Kaiser, E., P. Chiba, and K. Zaky. 1990. Phospholipases in biology and medicine. Clin. Biochem. 23:349-370.
15. Ferguson, J. E., and M. R. Hanley. 1991. The role of phospholipases and phospholipid-derived signals in cell activation. Curr. Opin. Cell Biol. 3:206-212.
16. Dixon, R. A., R. E. Diehl, E. Opas, E. Rands, P. J. Vickers, J. F. Evans, J. W. Gillard, and D. K. Miller. 1990. Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343:282-284.
17. Miller, D. K., J. W. Gillard, P. J. Vickers, S. Sadowski, C. Leveille, J. A. Mancini, et al. 1990. Identification and isolation of a membrane protein necessary for leukotriene production. Nature 343:278-281.
18. Reid, G. K., S. Kargman, P. J. Vickers, J. A. Mancini, C. Leveille, D. Ethier, D. K. Miller, J. W. Gillard, R. A. Dixon, and J. F. Evans. 1990. Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J. Biol. Chem. 265:19818-19823.
19. Woods, J. W., J. F. Evans, D. Ethier, S. Scott, P. J. Vickers, L. Hearn, J. A. Heibein, S. Charleson, and I. I. Singer. 1993. 5-Lipoxygenase and 5-lipoxygenase activating protein are localized in the nuclear envelope of activated human leukocytes. J. Exp. Med. 178:1935-1946.